Brief: CNS Pharma Announces Agreement to Extend Term of CEO John Climaco
Sept 4 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS - ON SEPT 1 ENTERED INTO AMENDMENT TO
EMPLOYMENT AGREEMENT WITH JOHN CLIMACO PURSUANT TO WHICH CLIMACO
SERVES AS CO'S CEO
* CNS PHARMACEUTICALS INC - AMENDMENT EXTENDS TERM OF
EMPLOYMENT
UNDER EMPLOYMENT AGREEMENT, FOR ADDITIONAL 12-MONTH PERIODS
Source text: (https://bit.ly/3i20UbY)
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026